Clinical Trial

Neuroimaging Studies of Reward Processing in Depression

Study Description

Neuroimaging Studies of Reward Processing in Depression

This study investigates stress-related signaling of glutamate and dopamine within the reward-processing circuit in Major Depressive Disorder (MDD), and whether they can be used to predict depressive symptoms in the future. This will be achieved through various neuroimaging tools (MRS, fMRI, PET), behavioral tasks, and a naturalistic follow-up design.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Radiation - PET Scan with Raclopride

A subsample (21 per group) will complete the PET imaging.

Additional Information

Official Study Title

Neuroimaging Studies of Reward Processing in Depression

Clinical Trial ID

NCT03026036

ParticipAid ID

Qe1PVd